Medicare Enrolled

Dr. Michelle Costa, D.O.

Rheumatology · Falmouth, MA
Speaking/Promotional
90 TER HEUN DRIVE, Falmouth, MA 02540
5084957160
In practice since 2007 (19 years)
NPI: 1962548941 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Costa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Costa? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Costa

Dr. Michelle Costa is a rheumatology specialist in Falmouth, MA, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Costa received a total of $6,438 from 19 pharmaceutical and/or device companies across 83 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Costa is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $6,438 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,438
Total received (2018-2024)
Avg $1,073/year across 6 years
Top 30% in MA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
19
Companies
83
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,846 (75.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,592 (24.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$152
2022
$115
2021
$290
2020
$117
2019
$431
2018
$5,333

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$108
Medline Industries LP
$44
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$4,956
ABBVIE INC.
$222
Lilly USA, LLC
$192
AbbVie Inc.
$180
PFIZER INC.
$138
Amgen Inc.
$138
GlaxoSmithKline, LLC.
$125
Janssen Scientific Affairs, LLC
$124
Novartis Pharmaceuticals Corporation
$71
Integra LifeSciences Corporation
$48
Medline Industries LP
$44
E.R. Squibb & Sons, L.L.C.
$43
Novo Nordisk Inc
$33
Shire North American Group Inc
$33
Abbott Laboratories
$25
Janssen Biotech, Inc.
$19
Janssen Pharmaceuticals, Inc
$16
Merck Sharp & Dohme Corporation
$15
Medtronic MiniMed, Inc.
$15
Top 3 companies account for 83.4% of all-time payments
Associated products mentioned in payments ›
AMNIOEXCEL · BENLYSTA · COSENTYX · Enbrel · FORTEO · FreeStyle Libre blood glucose Flash Monitoring System · Guardian Sensor 3 · HUMIRA · Humira · JANUVIA · NATPARA (PARATHYROID HORMONE) · ORENCIA · Ozempic · Prolia · RINVOQ · Repatha · Rinvoq · SIMPONI · SKYRIZI · STELARA · TALTZ · Victoza · XARELTO · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (75%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware.

Looking for a rheumatology specialist in Falmouth?
Compare rheumatologists in the Falmouth area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
12
Per 100K population
5.2
County median income
$94,452
Nearest hospital
FALMOUTH HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Costa is a rheumatology specialist, with speaking/promotional industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Costa receive payments from pharmaceutical companies?
Yes. Dr. Costa received a total of $6,438 from 19 companies across 83 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Costa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Rheumatologists in Falmouth
Browse rheumatologists in Falmouth ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in MA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in MA
Which MA rheumatologists receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →